MetaCap

Outset Medical (OM) vs Valion Bio (VBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Outset Medical is the larger company by market cap ($79.1 million vs $1.9 million), about 40.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

OM versus VBIO key metrics
MetricOMVBIO
Share price$4.21$2.19
Market cap$79.14M$1.94M
1-day change+1.69%-7.98%
YTD return+13.48%—
1-year return-71.95%—
5-year return-99.42%—
EPS (TTM)$-4.06$-161.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$16.16$78.75
52-week low$2.84$2.05
Distance from 52-week high-73.95%-97.22%
Average volume160.91K1.46M
Shares outstanding18.80M887.59K
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Outset Medical is about 40.7 times larger than Valion Bio by market value ($79.14M vs $1.94M).

OM vs VBIO FAQ

Which is bigger, Outset Medical or Valion Bio?

Outset Medical (OM) is larger, with a market capitalization of $79.14M compared with $1.94M for Valion Bio (VBIO).

Are Outset Medical and Valion Bio in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons